CoChat

Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment

Open access
Hanks, Brent A., Holtzhausen, Alisha, Evans, Katherine S., Jamieson, Rebekah, Gimpel, Petra, Campbell, Olivia M., Hector-Greene, Melissa, Sun, Lihong, Tewari, Alok, George, Amanda, Starr, Mark, Nixon, Andrew, Augustine, Christi, Beasley, Georgia, Tyler, Douglas S., Osada, Takayu, Morse, Michael A., Ling, Leona, Lyerly, H. Kim, Blobe, Gerard C. · 2013 · Journal of Clinical Investigation
Cited by 120

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Cancers subvert the host immune system to facilitate disease progression. These evolved immunosuppressive mechanisms are also implicated in circumventing immunotherapeutic strategies. Emerging data indicate that local tumor-associated DC populations exhibit tolerogenic features by promoting Treg development; however, the mechanisms by which tumors manipulate DC and Treg function in the tumor microenvironment remain unclear. Type III TGF-β receptor (TGFBR3) and its shed extracellular domain (sTGFBR3) regulate TGF-β signaling and maintain epithelial homeostasis, with loss of TGFBR3 expression promoting progression early in breast cancer development. Using murine models of breast cancer and melanoma, we elucidated a tumor immunoevasion mechanism whereby loss of tumor-expressed TGFBR3/sTGFBR3 enhanced TGF-β signaling within locoregional DC populations and upregulated both the immunoregulatory enzyme indoleamine 2,3-dioxygenase (IDO) in plasmacytoid DCs and the CCL22 chemokine in myeloid DCs. Alterations in these DC populations mediated Treg infiltration and the suppression of antitumor immunity. Our findings provide mechanistic support for using TGF-β inhibitors to enhance the efficacy of tumor immunotherapy, indicate that sTGFBR3 levels could serve as a predictive immunotherapy biomarker, and expand the mechanisms by which TGFBR3 suppresses cancer progression to include effects on the tumor immune microenvironment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci65745

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 120

Metadata

Authors
Hanks, B. A., Holtzhausen, A., Evans, K. S., Jamieson, R., Gimpel, P., Campbell, O. M., Hector-Greene, M., Sun, L., Tewari, A., George, A., Starr, M., Nixon, A., Augustine, C., Beasley, G., Tyler, D. S., Osada, T., Morse, M. A., Ling, L., Lyerly, H. K., & Blobe, G. C.
Venue
Journal of Clinical Investigation
Published
2013-08-08
Volume
123
Issue
9
Pages
3925-3940
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2152512826
Cited by
120
References
10
FWCI
4.71
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment. https://app.cochat.ai/papers/10.1172/jci65745
The paper
Hanks, B. A., Holtzhausen, A., Evans, K. S., Jamieson, R., Gimpel, P., Campbell, O. M., Hector-Greene, M., Sun, L., Tewari, A., George, A., Starr, M., Nixon, A., Augustine, C., Beasley, G., Tyler, D. S., Osada, T., Morse, M. A., Ling, L., Lyerly, H. K., & Blobe, G. C. (2013). Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment. Journal of Clinical Investigation. https://doi.org/10.1172/jci65745

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.